The document discusses preformulation, which involves characterizing a drug's physicochemical properties to aid in developing a stable and effective dosage form. Some key goals of preformulation testing are to determine solubility, stability, and compatibility with excipients. Various analytical techniques are used to evaluate properties like polymorphism, particle size, and purity that can impact drug performance. The results of preformulation studies provide critical information to formulation scientists in designing an optimal drug delivery system.
1. Preformulation studies characterize the physical and chemical properties of drug molecules to develop safe, effective, and stable dosage forms.
2. Key areas of preformulation include evaluating organoleptic properties, bulk characterization, solubility analysis, and stability analysis.
3. Important parameters studied are particle size, hygroscopicity, crystallinity, polymorphism, and powder flow properties which can impact drug dissolution, bioavailability, stability and manufacturability of dosage forms.
1. Preformulation testing involves characterizing key properties of drugs and excipients to develop safe, effective, and stable dosage forms. Tests include analyzing organoleptic properties, purity, solubility, hygroscopicity, and compatibility.
2. Analytical methods are important to quantify drugs during product development and stability testing. UV and HPLC methods are often used depending on the drug's chromophores.
3. Solubility studies over the pH range of 1-8 are crucial because permeability and absorption depend on a drug's ionization state and solubility in different regions of the gastrointestinal tract.
The document discusses preformulation studies that are conducted to characterize new drug compounds and optimize their molecular form prior to formulation development. Key goals are to determine physicochemical properties, identify any issues like poor solubility, and decide on modifications like salt formation or use of prodrugs to improve properties. Techniques discussed include thermal analysis to identify polymorphic forms, hydrates, purity and degradation risks. The objective is to select the best molecular form of a drug to enter the development process and enable creation of stable, effective drug products.
Pre-formulation studies involve evaluating the physical and chemical properties of an active pharmaceutical ingredient prior to formulation development. This helps understand the drug's behavior and identify suitable excipients and dosage forms. Key aspects of pre-formulation studies include evaluating solubility, stability, dissolution rate, and compatibility with excipients. Techniques like DSC, FTIR, XRD are used to analyze properties like crystallinity, polymorphism and for compatibility testing. Together, pre-formulation studies provide critical data to inform the rational development of a stable and effective dosage form.
The document discusses preformulation studies, which characterize a new drug substance's physical and chemical properties to develop stable, safe dosage forms. Key goals are to establish the drug's properties, compatibility with excipients, and kinetic profile. Studies examine various physical parameters like appearance, particle size, flow properties, and chemical properties like solubility, polymorphism, hygroscopicity, and stability. This information guides dosage form development to deliver drugs efficiently and consistently.
The document discusses various physicochemical properties that can affect bioequivalence studies, including crystal morphology, polymorphism, solvates, hydrates, complexation, surface activity, hygroscopicity, particle size, solubility and dissolution. It explains how these properties can influence parameters like raw material characteristics, reproducibility, performance of the dosage form, absorption rate and extent. Factors like ionization, partitioning, distribution coefficient, chemical structure and salt forms are also covered in relation to their effects on solubility, dissolution and absorption of drug substances and products.
The document provides an overview of pre-formulation, which involves determining the physicochemical properties of a drug substance prior to developing a dosage form. It discusses the goals of pre-formulation to formulate an efficacious dosage form with good bioavailability. The protocol involves characterizing the physical, chemical, solubility, stability and compatibility properties of the drug. Key aspects covered include polymorphism, hygroscopicity, particle size, solubility, dissolution, stability in solution and solid state, and compatibility with excipients. The information guides subsequent formulation development.
This document discusses various preformulation techniques used to improve the solubility and dissolution rate of poorly soluble drugs. It describes solubilization methods like surfactants, pH adjustment, cosolvency and solid dispersions using carriers like 硫-cyclodextrin. Key factors that influence dissolution like temperature, surface area, and hydrodynamics based on the Noyes-Whitney equation are also covered. The importance of preformulation properties like pKa, solubility and polymorphism on drug development are highlighted. References on industrial pharmacy and pharmaceutical dosage forms are listed for further reading.
This document discusses key concepts in preformulation testing. It begins by defining preformulation as investigating the physical and chemical properties of a drug substance alone and combined with excipients. The overall goal is to generate information useful for developing stable and safe dosage forms.
It then outlines some of the main steps in preformation process including assessing organoleptic properties, purity, particle size, melting point, stability, excipient compatibility, solubility, polymorphism, pH and salt formation. Specific tests are mentioned for many of these areas.
The document emphasizes that preformulation is important for aiding drug candidate selection, product design, decreasing time to market, and ensuring overall safety and efficacy of the final product
This document discusses preformulation studies, which involve characterizing the physical and chemical properties of drug substances prior to formulation development. It covers key topics like solubility profiling, polymorphism, particle size analysis, and flow properties. The goals are to establish parameters for new drugs and provide scientific data to support dosage form design and stability. Understanding preformulation can help develop stable, safe, and effective drug products.
This document discusses various techniques to improve the solubility of poorly soluble drugs, which is important for developing effective dosage forms and achieving desired drug concentrations. It defines solubility and discusses the importance of solubility in drug development. Some key techniques covered are co-solvency, use of surfactants, solid dispersions, complexation, changing temperature, hydrotropy, polymorphism, amorphous forms, solvates, salt formation, and micronization/nanonization. The goal is to select the optimal method for a given drug to enhance dissolution and absorption.
This document discusses the need for dosage forms and pre-formulation studies. It notes that dosage forms are needed to safely and conveniently deliver accurate drug doses while protecting drugs from environmental factors. Pre-formulation studies characterize the physical and chemical properties of drug substances to aid in the development of stable and effective dosage forms. These studies determine properties like solubility, stability, and compatibility with excipients. Understanding these properties provides insights to ensure quality during processing and storage.
This document discusses excipients and their role in drug formulations. It notes that excipients are ingredients other than the active pharmaceutical ingredient that are used to formulate dosage forms. Excipients can act as protective agents, bulking agents, and can improve drug bioavailability. The document then lists common types of excipients and potential interactions between drugs and excipients, such as physical, chemical, biopharmaceutical, and excipient-excipient interactions. It describes several analytical techniques used to detect drug-excipient interactions, including DSC, accelerated stability studies, FT-IR, DRS, chromatography methods, and others.
The document discusses various techniques for enhancing the solubility and dissolution of poorly soluble drug compounds. It begins by defining concepts like solubility, dissolution, and factors that affect them. Then it describes several techniques including physical modifications like particle size reduction and polymorphism, chemical modifications like changing pH and forming salts, and use of surfactants, microemulsions, and self-emulsifying drug delivery systems. Specific methods discussed in detail include nanosuspensions, nanomorph technology, and use of polymers for solubility enhancement.
This document discusses preformulation studies, which are important steps in developing an effective dosage form for a new drug. The objectives of preformulation studies are to establish the physico-chemical properties of the drug substance and generate information to design an optimal drug delivery system. Key aspects investigated include solubility, stability, compatibility with excipients, and parameters like particle size, bulk density and flow properties. Thorough preformulation work provides a foundation for formulation development and identifies potential problems to address.
SOLID DISPERSION
Definition: The technology is the science of dispersing one or more active ingredients in an inert matrix in the solid stage.
Need of solid dispersion:
Increases Oral bioavailability of a drug
Increased dissolution rate.
Enhanced release of drugs from ointment.
Improved the solubility & stability.
The concept of solid dispersion was originally proposed by Sekiguchi & obi.
Increasing the dissolution, absorption & therapeutic efficacy of drugs in dosage forms.
Increasing solubility in water.
Improving the oral absorption and bioavailability of BCS Class II drugs.
Definition: Preformulation is the first step in the rational development of dosages form of a drug substance/new chemical entity. It can be defined as an investigation of physical and chemical properties of the drug substances alone and when combined with excipients, in order to develop a stable, safe, effective and affordable dosage form.
Objectives:
To develop the elegant dosage forms (stable, safe, effective and affordable).
It is important to have an understanding of the physical description of a drug substance before dosage form development.
It is first step in rational development of a dosage form of a drug substance before dosage form development.
It generates useful information to the formulator to design an optimum drug delivery system.
Goals:
To establish the physico-chemical parameters of new drug substance.
To establish the physical characteristics.
To establish the kinetic rate profile.
To establish the compatibility with the common excipient.
Preformulation involves characterizing the physical and chemical properties of new drug molecules to aid in developing safe and stable dosage forms. It provides direction for choosing the dosage form, excipients, composition and process development. Key factors studied include the drug's physical characteristics like crystallinity, hygroscopicity and solubility, as well as its chemical stability when exposed to conditions like oxidation, hydrolysis and photolysis. Understanding how the drug behaves under various conditions helps ensure the dosage form maintains integrity during storage and use.
The document discusses drug-excipient compatibility studies. It notes the importance of such studies in maximizing stability and avoiding formulation problems. The goals are outlined as determining which excipients stabilize drugs and assigning risk levels. Mechanisms of interaction include physical interactions like complexation or adsorption, and chemical interactions like hydrolysis or oxidation. Analytical methods to detect interactions include thermal techniques like DSC and microcalorimetry, and spectroscopic techniques like IR and Raman spectroscopy. The document provides details on several of these techniques.
This document discusses preformulation studies, which characterize the physicochemical properties of new drug molecules to develop safe, effective, and stable dosage forms. It covers various areas of preformulation research like organoleptic properties, bulk characterization, crystallinity, polymorphism, hygroscopicity, micromeritic properties, solubility, pKa determination, and stability studies. Analytical techniques used for characterization include microscopy, DSC, IR, XRD, SEM, and TGA. The goals of preformulation are to establish the drug's properties, determine its kinetics and stability, ensure compatibility with excipients, and improve the drug product's manufacturing, storage and performance.
This document discusses preformulation studies, which involve characterizing the physical and chemical properties of a drug prior to formulation. The goals are to establish parameters like solubility, stability, and compatibility with excipients. Key areas discussed include solubility studies like determining pKa and performing partition coefficient experiments. Bulk characterization of properties like crystallinity, hygroscopicity and micromeritics are also covered. The document concludes with an overview of stability analysis of drug solutions and solids as well as drug-excipient compatibility testing.
Complexometric titration involves titrating a metal ion with a complexing agent like EDTA. Magnesium sulfate can be estimated by direct titration with EDTA in the presence of ammonia-ammonium chloride buffer using an indicator. The magnesium ions form a complex with EDTA until the equivalence point is reached, indicated by a color change of the indicator. This direct titration method provides an accurate determination of the magnesium content in magnesium sulfate.
More Related Content
Similar to preformulation study ralated to pharmaceuticals (20)
The document provides an overview of pre-formulation, which involves determining the physicochemical properties of a drug substance prior to developing a dosage form. It discusses the goals of pre-formulation to formulate an efficacious dosage form with good bioavailability. The protocol involves characterizing the physical, chemical, solubility, stability and compatibility properties of the drug. Key aspects covered include polymorphism, hygroscopicity, particle size, solubility, dissolution, stability in solution and solid state, and compatibility with excipients. The information guides subsequent formulation development.
This document discusses various preformulation techniques used to improve the solubility and dissolution rate of poorly soluble drugs. It describes solubilization methods like surfactants, pH adjustment, cosolvency and solid dispersions using carriers like 硫-cyclodextrin. Key factors that influence dissolution like temperature, surface area, and hydrodynamics based on the Noyes-Whitney equation are also covered. The importance of preformulation properties like pKa, solubility and polymorphism on drug development are highlighted. References on industrial pharmacy and pharmaceutical dosage forms are listed for further reading.
This document discusses key concepts in preformulation testing. It begins by defining preformulation as investigating the physical and chemical properties of a drug substance alone and combined with excipients. The overall goal is to generate information useful for developing stable and safe dosage forms.
It then outlines some of the main steps in preformation process including assessing organoleptic properties, purity, particle size, melting point, stability, excipient compatibility, solubility, polymorphism, pH and salt formation. Specific tests are mentioned for many of these areas.
The document emphasizes that preformulation is important for aiding drug candidate selection, product design, decreasing time to market, and ensuring overall safety and efficacy of the final product
This document discusses preformulation studies, which involve characterizing the physical and chemical properties of drug substances prior to formulation development. It covers key topics like solubility profiling, polymorphism, particle size analysis, and flow properties. The goals are to establish parameters for new drugs and provide scientific data to support dosage form design and stability. Understanding preformulation can help develop stable, safe, and effective drug products.
This document discusses various techniques to improve the solubility of poorly soluble drugs, which is important for developing effective dosage forms and achieving desired drug concentrations. It defines solubility and discusses the importance of solubility in drug development. Some key techniques covered are co-solvency, use of surfactants, solid dispersions, complexation, changing temperature, hydrotropy, polymorphism, amorphous forms, solvates, salt formation, and micronization/nanonization. The goal is to select the optimal method for a given drug to enhance dissolution and absorption.
This document discusses the need for dosage forms and pre-formulation studies. It notes that dosage forms are needed to safely and conveniently deliver accurate drug doses while protecting drugs from environmental factors. Pre-formulation studies characterize the physical and chemical properties of drug substances to aid in the development of stable and effective dosage forms. These studies determine properties like solubility, stability, and compatibility with excipients. Understanding these properties provides insights to ensure quality during processing and storage.
This document discusses excipients and their role in drug formulations. It notes that excipients are ingredients other than the active pharmaceutical ingredient that are used to formulate dosage forms. Excipients can act as protective agents, bulking agents, and can improve drug bioavailability. The document then lists common types of excipients and potential interactions between drugs and excipients, such as physical, chemical, biopharmaceutical, and excipient-excipient interactions. It describes several analytical techniques used to detect drug-excipient interactions, including DSC, accelerated stability studies, FT-IR, DRS, chromatography methods, and others.
The document discusses various techniques for enhancing the solubility and dissolution of poorly soluble drug compounds. It begins by defining concepts like solubility, dissolution, and factors that affect them. Then it describes several techniques including physical modifications like particle size reduction and polymorphism, chemical modifications like changing pH and forming salts, and use of surfactants, microemulsions, and self-emulsifying drug delivery systems. Specific methods discussed in detail include nanosuspensions, nanomorph technology, and use of polymers for solubility enhancement.
This document discusses preformulation studies, which are important steps in developing an effective dosage form for a new drug. The objectives of preformulation studies are to establish the physico-chemical properties of the drug substance and generate information to design an optimal drug delivery system. Key aspects investigated include solubility, stability, compatibility with excipients, and parameters like particle size, bulk density and flow properties. Thorough preformulation work provides a foundation for formulation development and identifies potential problems to address.
SOLID DISPERSION
Definition: The technology is the science of dispersing one or more active ingredients in an inert matrix in the solid stage.
Need of solid dispersion:
Increases Oral bioavailability of a drug
Increased dissolution rate.
Enhanced release of drugs from ointment.
Improved the solubility & stability.
The concept of solid dispersion was originally proposed by Sekiguchi & obi.
Increasing the dissolution, absorption & therapeutic efficacy of drugs in dosage forms.
Increasing solubility in water.
Improving the oral absorption and bioavailability of BCS Class II drugs.
Definition: Preformulation is the first step in the rational development of dosages form of a drug substance/new chemical entity. It can be defined as an investigation of physical and chemical properties of the drug substances alone and when combined with excipients, in order to develop a stable, safe, effective and affordable dosage form.
Objectives:
To develop the elegant dosage forms (stable, safe, effective and affordable).
It is important to have an understanding of the physical description of a drug substance before dosage form development.
It is first step in rational development of a dosage form of a drug substance before dosage form development.
It generates useful information to the formulator to design an optimum drug delivery system.
Goals:
To establish the physico-chemical parameters of new drug substance.
To establish the physical characteristics.
To establish the kinetic rate profile.
To establish the compatibility with the common excipient.
Preformulation involves characterizing the physical and chemical properties of new drug molecules to aid in developing safe and stable dosage forms. It provides direction for choosing the dosage form, excipients, composition and process development. Key factors studied include the drug's physical characteristics like crystallinity, hygroscopicity and solubility, as well as its chemical stability when exposed to conditions like oxidation, hydrolysis and photolysis. Understanding how the drug behaves under various conditions helps ensure the dosage form maintains integrity during storage and use.
The document discusses drug-excipient compatibility studies. It notes the importance of such studies in maximizing stability and avoiding formulation problems. The goals are outlined as determining which excipients stabilize drugs and assigning risk levels. Mechanisms of interaction include physical interactions like complexation or adsorption, and chemical interactions like hydrolysis or oxidation. Analytical methods to detect interactions include thermal techniques like DSC and microcalorimetry, and spectroscopic techniques like IR and Raman spectroscopy. The document provides details on several of these techniques.
This document discusses preformulation studies, which characterize the physicochemical properties of new drug molecules to develop safe, effective, and stable dosage forms. It covers various areas of preformulation research like organoleptic properties, bulk characterization, crystallinity, polymorphism, hygroscopicity, micromeritic properties, solubility, pKa determination, and stability studies. Analytical techniques used for characterization include microscopy, DSC, IR, XRD, SEM, and TGA. The goals of preformulation are to establish the drug's properties, determine its kinetics and stability, ensure compatibility with excipients, and improve the drug product's manufacturing, storage and performance.
This document discusses preformulation studies, which involve characterizing the physical and chemical properties of a drug prior to formulation. The goals are to establish parameters like solubility, stability, and compatibility with excipients. Key areas discussed include solubility studies like determining pKa and performing partition coefficient experiments. Bulk characterization of properties like crystallinity, hygroscopicity and micromeritics are also covered. The document concludes with an overview of stability analysis of drug solutions and solids as well as drug-excipient compatibility testing.
Complexometric titration involves titrating a metal ion with a complexing agent like EDTA. Magnesium sulfate can be estimated by direct titration with EDTA in the presence of ammonia-ammonium chloride buffer using an indicator. The magnesium ions form a complex with EDTA until the equivalence point is reached, indicated by a color change of the indicator. This direct titration method provides an accurate determination of the magnesium content in magnesium sulfate.
skin cosmetics for m.pharm student & B.pharm studentLaxmidharSahoo11
油
The document discusses acne, its causes and treatment. Acne occurs when oil and dead skin cells block pores, causing oil to build up and bacteria to grow. It progresses from clogged pores to bacterial overgrowth and inflammation. Treatment includes topical medications containing benzoyl peroxide, salicylic acid, and antibiotics. Stress and hormonal changes can worsen acne symptoms.
This document discusses analytical method validation. It introduces the importance of validating analytical procedures to ensure accurate and precise results. It describes common validation characteristics including accuracy, precision, specificity, linearity, range, detection/quantitation limits, and robustness. The document provides detailed definitions and procedures for evaluating each validation characteristic to demonstrate an analytical method is fit for its intended use.
This document discusses acid-base titration and indicators. It defines acid-base titration as a quantitative analysis that involves neutralizing an acid or base of unknown concentration with an acid or base of known concentration. The equivalence point occurs when the titrant has exactly neutralized the analyte and allows calculating the concentration of the unknown acid or base. It also describes the Ostwald and quinonoid theories for how acid-base indicators work by changing color depending on their state of ionization or structural form under acidic or basic conditions.
Standardization is the process of determining the concentration of a solution by reacting it quantitatively with a standard solution. Primary standards are highly pure, stable reagents used to standardize and prepare secondary standards. They have properties like high purity, stability, and molecular weight. Primary standards like sodium chloride and sodium carbonate are used to standardize silver nitrate and acid solutions respectively. Accurate standardization is important for titration calculations which rely on knowing the true concentration of the standard solution.
APM People Interest Network Conference 2025
-Autonomy, Teams and Tension: Projects under stress
-Tim Lyons
-The neurological levels of
team-working: Harmony and tensions
With a background in projects spanning more than 40 years, Tim Lyons specialised in the delivery of large, complex, multi-disciplinary programmes for clients including Crossrail, Network Rail, ExxonMobil, Siemens and in patent development. His first career was in broadcasting, where he designed and built commercial radio station studios in Manchester, Cardiff and Bristol, also working as a presenter and programme producer. Tim now writes and presents extensively on matters relating to the human and neurological aspects of projects, including communication, ethics and coaching. He holds a Masters degree in NLP, is an NLP Master Practitioner and International Coach. He is the Deputy Lead for APMs People Interest Network.
Session | The Neurological Levels of Team-working: Harmony and Tensions
Understanding how teams really work at conscious and unconscious levels is critical to a harmonious workplace. This session uncovers what those levels are, how to use them to detect and avoid tensions and how to smooth the management of change by checking you have considered all of them.
How to Configure Restaurants in Odoo 17 Point of SaleCeline George
油
Odoo, a versatile and integrated business management software, excels with its robust Point of Sale (POS) module. This guide delves into the intricacies of configuring restaurants in Odoo 17 POS, unlocking numerous possibilities for streamlined operations and enhanced customer experiences.
Research & Research Methods: Basic Concepts and Types.pptxDr. Sarita Anand
油
This ppt has been made for the students pursuing PG in social science and humanities like M.Ed., M.A. (Education), Ph.D. Scholars. It will be also beneficial for the teachers and other faculty members interested in research and teaching research concepts.
Mate, a short story by Kate Grenvile.pptxLiny Jenifer
油
A powerpoint presentation on the short story Mate by Kate Greenville. This presentation provides information on Kate Greenville, a character list, plot summary and critical analysis of the short story.
Digital Tools with AI for e-Content Development.pptxDr. Sarita Anand
油
This ppt is useful for not only for B.Ed., M.Ed., M.A. (Education) or any other PG level students or Ph.D. scholars but also for the school, college and university teachers who are interested to prepare an e-content with AI for their students and others.
Blind spots in AI and Formulation Science, IFPAC 2025.pdfAjaz Hussain
油
The intersection of AI and pharmaceutical formulation science highlights significant blind spotssystemic gaps in pharmaceutical development, regulatory oversight, quality assurance, and the ethical use of AIthat could jeopardize patient safety and undermine public trust. To move forward effectively, we must address these normalized blind spots, which may arise from outdated assumptions, errors, gaps in previous knowledge, and biases in language or regulatory inertia. This is essential to ensure that AI and formulation science are developed as tools for patient-centered and ethical healthcare.
The Constitution, Government and Law making bodies .saanidhyapatel09
油
This PowerPoint presentation provides an insightful overview of the Constitution, covering its key principles, features, and significance. It explains the fundamental rights, duties, structure of government, and the importance of constitutional law in governance. Ideal for students, educators, and anyone interested in understanding the foundation of a nations legal framework.
Prelims of Kaun TALHA : a Travel, Architecture, Lifestyle, Heritage and Activism quiz, organized by Conquiztadors, the Quiz society of Sri Venkateswara College under their annual quizzing fest El Dorado 2025.
Finals of Rass MELAI : a Music, Entertainment, Literature, Arts and Internet Culture Quiz organized by Conquiztadors, the Quiz society of Sri Venkateswara College under their annual quizzing fest El Dorado 2025.
SOCIAL CHANGE(a change in the institutional and normative structure of societ...DrNidhiAgarwal
油
This PPT is showing the effect of social changes in human life and it is very understandable to the students with easy language.in this contents are Itroduction, definition,Factors affecting social changes ,Main technological factors, Social change and stress , what is eustress and how social changes give impact of the human's life.
2. Introduction:
Preformulation testing is considered as the first step
before rational development of the dosage form with
a drug molecule.
It involves the exploitation of biopharmaceuticals
principles in selecting the right excipient, right
composition, right processing steps, and right
packaging materials
So, the Preformulation testing is considered the
fundamental aspect of developing robust
formulations and can be considered as a learning
process before actually developing the dosage forms
4. Disciplines
Medicinal Chemistry and Pharmacology
Pre-formulation Research
Formulation development
Process R&D
Analytical R&D
Toxicology and drug metabolism
5. Definition:
Preformulation study is defined as the stage of
research and development in which Preformulation
scientist characterize physical and chemical
properties of a drug molecule in order to develop
safe, effective and stable dosage form
6. When???
If the drug shows sufficient activity in animals &
is to be evaluated in humans.
Focus
On physicochemical properties of a new
compound which may affect the drug
performance &development of efficacious dosage
form.
7. Objectives:
The preformulation investigations confirm that
there are no significant barriers to the
compounds development as a marketed drug.
The formulation scientist uses these informations
to develop dosage forms.
8. Goals of Preformulation:
To generate useful information to the formulator to
design an optimum drug delivery system.
To establish the necessary physicochemical
parameters of new drug substances.
To determine kinetic rate profile.
To establish physical characteristics.
To establish compatibility with common excipients
10. Preformulation parameters Method used
Organoleptic Properties Colour and odour determination
Crystallinity & Polymorphism X-ray Diffraction Studies
Fine Particle Characterization Microscopic Method
Solubility Profile Equilibrium Solubility Method
Analytical Method Development UV Spectroscopic Method, HPLC Method
Ionization Constant, pKa Determination of Spectral Shifts by UV
Spectroscopy
Partition Coefficient Using octanol / water
Bulk Density Tapping Method
Powder Flow Properties % Compressibility Determination, Angle of
Repose
Compatibility With Excipient DSC
Stability Solution and Solid State Stability
Stability Indicating Method
Development
Forced Degradation Studies
11. Principal area of preformulation research
I.Organoleptic properties
Purity of API & excipient
Particle size,shape,surface area
II.Bulk characterization
Crystalinity & polymorphism
Hygroscopicity
Fine particle characterization
Bulk density
Powder flow properties
III. Solubility analysis
Ionization constant-pKa
pH solubility profile
Common ion effect
Thermal effect
Solubilization
Partition coefficient
Dissolution
IV. Stability analysis
Stability in toxicology formulation
Solution stability
pH rate profile
Solid state stability
Bulk stability
compatibity
12. Organoleptic properties
It refers to the evaluation of drugs by properties like
colour, odour, taste
An active ingredient must be palatable as well as have
a good aroma in case its not the case then additives
like flavours or coating can be done to mask out the
taste or hide the intense smell which is otherwise not
acceptable.
For example:
Pungent or sulphur smelling ingredients must be
covered with an acceptable odorous
compound similarly bland or bitter drugs can be
masked for taste.
13. Purity of API and excipient
These solid drugs are pure organic compounds that exist as
either crystalline or amorphous.
The purity of the chemical substance is considered as its
essential quality to comply with various Pharmacopoeial tests
including therapeutic efficacy.
Melting point of a chemical substance is considered its
intrinsic property which can be used as an indicator of purity of
that substance.
As an example, a pure crystalline API can be identified by its
unique and very sharp melting temperature determined by
capillary method.
Apart from that method, purity of an API can be determined
by HPLC, TLC, DSC, or GC. In chromatographic methods,
reference standard of an API is considered 100% pure and
unknown samples are compared against that reference standard
14. Impurities found in common excipient
Excipient Impurity
Lactose Aldehydes
Benzyl alcohol Benzaldehyde
Polyethylene glycol Aldehydes, peroxides, organic
acids
Microcrystalline cellulose Lignin, hemicelluloses, water
Starch Formaldehyde
Talc Heavy metals
Stearate lubricants Alkaline residues
15. Particle Size, Shape, and Surface Area
Certain physical properties, chemical reactivity,
stability, bioavailability, content uniformity,
sedimentation rate, flow and mixing homogeneity of
powders and granules depend on particle size
distribution and shape
Particle size determination
Microscopy..
Anderson Pipette
Sieving method
Instruments based on light blockage(HIAC) and
blockage of electrical conductivity path(coulter
Counter) are available
16. Shape determination:
Microscopy should be carried out to determine
the ratio of longest to shortest dimension. It is a
shape factor.
Surface area determination: The measurement
of surface area is made by Brunauer,Emmett,and
Teller (BET) nitrogen adsorption
By using Scanning electron Microscopy (SEM)
18. Habit is the description of the outer appearance of
a crystal. A single internal-structure for a
compound can have several different habits,
depending on the environment for growing
crystals.
Different habits of crystals are given below.
Platy
Needle or Acicular
Tabular
Equant or Massive
Bladed
Prismatic
Fig. 1
19. Internal Structure
Crystalline state
In this state of matter atoms or molecules are
arranged in highly ordered form and is associated
with three-dimensional array.
Amorphous forms
In this forms the solids do not have any fixed internal
structure. They have atoms or molecules randomly
placed as in a liquid.
e.g. Amorphous Novobiocin (prepared by rapid
precipitation, lyophillization or rapid cooling of
molten liquids )
20. Since amorphous are usually higher
thermodynamic energy than corresponding
crystalline forms, solubilities as well as dissolution
rates are greater
Upon storage amorphous solid tends to revert
to more stable form
Thermodynamic instability
(which occurs during bulk processing or within
dosage forms) major disadvantage
for developing an amorphous form.
21. Preparation
Amorphous forms are prepared by rapid
precipitation, lyophillization or rapid cooling of
molten liquids
Glass transition temperature, Tg
Tg is a characteristics temperatuer of amorphous
form. Below Tg the amorphous form will be brittle
and is described as glassy state. Above Tg the solid
becomes plastic or rubbery. So Tg is the minimum
temperature at which the solid becomes
amorphous (plastic) from glassy state.
22. Application:
Tg can be reduced by addition of plasticizers.
Plasticizer molecules, either disturb or distort
the molecular arrangements, thus they
reduce the Tg.
During milling, all the solids must remain
below Tg.
Amorphous novobiocin is more soluble and
has higher bioavailability than its crystalline
form.
23. Molecular Adducts
During the process of crystallization, some
compounds have a tendency to trap the solvent
molecules.
Non-Stoichiometric inclusion compounds (or adducts)
In these crystals solvent molecules are entrapped
within the crystal lattice and the number of solvent
molecules are not included in stoichiometric number.
Usually this adduct is undesirable owing to its lack of
reproducibility & should be avoided for development
24. Depending on the shape they are of three types
:-
(1) Channel
When the crystal contains continuous channels in
which the solvent molecule can be included. e.g .
Urea forms channel.
(2) Layers:- Here solvent molecules are
entrapped in between layers of crystals.
(3) Clathrates(Cage):- Solvent molecules are
entrapped within the cavity of the crystal from all
sides.
25. Stoichiometric inclusion compounds (or stoichiometric adducts)
This molecular complex has incorporated the crystallizing solvent
molecules into specific sites within the crystal lattice and has
stoichiometric number of solvent molecules complexed.
When the incorporated solvent is water, the complex is called
hydrates and when the solvent is other than water, the complex
is called solvates.
Depending on the ratio of water molecules within a complex
the following nomenclature is followed.
Anhydrous : 1 mole compound + 0 mole water
Hemihydrate: 1 mole compound + 遜 mole water
Monohydrate: 1 mole compound + 1 mole water
Dihydrate : 1 mole compound + 2 moles water
26. Identification of possible hydrate compounds
is important since aqueous solubilities can be
significantly less than their anhydrous form
Conversion of an anhydrous compound to a
hydrate with in the dosage form may reduce the
dissolution rate & extent of absorption
27. Crystallinity
Conversion of an anhydrous compound to a
hydrate with in the dosage form may reduce the
dissolution rate & extent of absorption
,.houra.,,hourn anhydrous compound to a
hydrate within the dosage form
may reduce the dissolution rate &
extent of drug absorption in the
dosage form may reduce the
dissolution rate & extent of drug
absorption
Hours
28. POLYMORPHISM
When crystals exists in more than one internal structure (i.e.
packing pattern) the various crystalline forms are called
polymorphs and the phenomenon is known as
polymorphism.
Depending on the thermodynamic stability, the polymorphs
are divided into
stable,
metastable
unstable.
Unstable form has a tendency to transform into stable form.
Metastable forms in dry state will remain stable, but if
melted or dissolved will form stable polymorph.
29. Characteristics of polymorphs
Characteristics Stable polymorph Metastable
polymorph
Unstable
polymorph
Packing of
molecules in crystal
lattice
Tightly packed Less tightly packed Loosely packed
Melting point Highest Moderate Lowest
Rate of dissolution Lowest Moderate Highest
30. Polymorphism and bioavailability
Many drugs are hydrophobic and have very limited
solubility in water. If the drug remains in several
polymorphic forms then the stable one will
produce the slowest rate of dissolution and it may
show minimum bioavailability.
For highly water soluble drugs, polymorphism does
not show any problem in dissolution rate
31. Example: Chloramphenicol palmitate has three
polymorphs 留 (stable), 硫 (metastable) and 粒
(unstable).
When chloramphenicol palmitate suspension is
prepared from 留 or 硫 polymorph it is found that
bioavailabilty is higher with the metastable form.
Example
aspirin: Two polymorphs of can be obtained by
recrystallization of aspirin from 95% ethanol or n-
hexane. The polymorph obtained from n-hexane is
found to have greater solubility in water than the
polymorph obtained from ethanol.
32. Types of polymorphs
1. Enatiotropic (one polymorphs can be reversibly
changed into another by varying temp &
pressure) (e.g sulfur)
2. Monotropic(one polymorphic form is unstable
at all temp & pressure) e.g -glyceryl stearate
During preformulation study ,it is importamt to
identify stable polymorphs at room temp and
determine whether polymorphic transition is
possible within the temp range used for
stability study and during processing(drying,
milling etc.)
33. Methods of characterization of
polymorphs
1. Hot stage microscopy,
2. Differential Thermal Analysis,
3. Differential Scanning Calorimetry
4. Thermogravimetric Analysis (TGA)
5. X-ray powder diffraction
6. IR-Spectroscopy